Additionally, Saha et al. conducted a multi‐omics analysis across cancers and found that PROM2, along with PROM1, differentially modulates prognosis: PROM2 overexpression was associated with poor clinical outcomes in several tumor types, including OC [52]. This evidence concerns the gene PROM2 and neoplasm.